Improving heart function by modulating myocardiocyte autophagy: A possible novel mechanism for cardiovascular protection of high-density lipoprotein

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Wang, Fan ^a   Ye, Ping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Autophagy; Heart function; Reconstituted high density lipoprotein; Sphingosine 1 phosphate

Indexed keywords

HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; CARDIOTONIC AGENT; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ARTICLE; AUTOPHAGY; CARDIAC MUSCLE CELL; CELL ACTIVATION; CELL DEATH; CELL SURVIVAL; DOWN REGULATION; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART PROTECTION; HYPOTHESIS; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANIMAL; CORONARY DISEASE; HEART MUSCLE CELL; HUMAN; PHYSIOLOGY;

ANIMALS; AUTOPHAGY; CARDIOTONIC AGENTS; CORONARY DISEASE; HEART FAILURE; HUMANS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MYOCYTES, CARDIAC; SPHINGOSINE;

EID: 84925884122     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-163     Document Type: Article

References (26)

1. Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E: PROVE IT-TIMI 22 Investigators. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2008, 51: 724-730. 10.1016/j.jacc.2007.10.038
2. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC: Treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007, 357: 1301-1310. 10.1056/NEJMoa064278
3. Spillmann F, Schultheiss HP, Tschöpe C, Van Linthout S: High-density lipoprotein-raising strategies: update 2010. Curr Pharm Des 2010, 16: 1517-1530. 10.2174/138161210791050988
4. Breton CV, Yin F, Wang X, Avol E, Gilliland FD, Araujo JA: HDL anti-oxidant function associates with LDL level in young adults. Atherosclerosis 2014, 232: 165-170. 10.1016/j.atherosclerosis.2013.10.034
5. Riwanto M, Landmesser U: High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J Lipid Res 2013, 54: 3227-3243. 10.1194/jlr.R037762
6. Gordon SM, Davidson WS: Apolipoprotein A-I mimetics and high-density lipoprotein function. Curr Opin Endocrinol Diabetes Obes 2012, 19: 109-114. 10.1097/MED.0b013e32835056d4
7. Waeber C, Walther T: Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction. Circ J 2014, 78: 795-802. 10.1253/circj.CJ-14-0178
8. Sattler K, Levkau B: Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. Cardiovasc Res 2009, 82: 201-211.
9. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y, Camerer E, Zheng YW, Huang Y, Cyster JG, Coughlin SR: Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007, 316: 295-298. 10.1126/science.1139221
10. Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, Parikh NS, Habrukowich C, Hla T: Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008, 102: 669-676. 10.1161/CIRCRESAHA.107.165845
11. Kontush A, Therond P, Zerrad A, Couturier M, Nègre-Salvayre A, De Souza JA, Chantepie S, Chapman MJ: Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: Relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 2007, 27: 1843-1849. 10.1161/ATVBAHA.107.145672
12. Tolle M, Pawlak A, Schuchardt M, Kawamura A, Tietge UJ, Lorkowski S, Keul P, Assmann G, Chun J, Levkau B, van der Giet M, Nofer JR: HDL-associated lysosphingolipids inhibit NAD (P) H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol 2008, 28: 1542-1548. 10.1161/ATVBAHA.107.161042
13. Hammad SM1, Al Gadban MM, Semler AJ, Klein RL: Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles. J Lipids 2012, 2012: 180705.
14. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schäfers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, Von Wnuck LK, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B: High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006, 114: 1403-1409. 10.1161/CIRCULATIONAHA.105.607135
15. Egom EE, Mamas MA, Soran H: HDL quality or cholesterol cargo: what really matters-spotlight on sphingosine-1-phosphate-rich HDL. Curr Opin Lipidol 2013, 24: 351-356. 10.1097/MOL.0b013e328361f822
16. Means CK, Brown JH: Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res 2009, 82: 193-200.
17. Tao R, Hoover HE, Honbo N, Kalinowski M, Alano CC, Karliner JS, Raffai R: High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol 2010, 298: H1022-H1028. 10.1152/ajpheart.00902.2009
18. Frias MA, Lang U, Gerber-Wicht C, James RW: Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Cardiovasc Res 2010, 85: 118-126. 10.1093/cvr/cvp289
19. De Meyer GRY, Martinet W: Autophagy in the cardiovascular system. Biochim Biophys Acta 2009, 1793: 1485-1495. 10.1016/j.bbamcr.2008.12.011
20. Rothermel BA, Hill JA: Autophagy in load-induced heart disease. Circ Res 2008, 103: 1363-1369. 10.1161/CIRCRESAHA.108.186551
21. Gustafsson AB, Gottlieb RA: Autophagy in ischemic heart disease. Circ Res 2009, 104: 150-158. 10.1161/CIRCRESAHA.108.187427
22. Kanamori H, Takemura G, Maruyama R, Goto K, Tsujimoto A, Ogino A, Li L, Kawamura I, Takeyama T, Kawaguchi T, Nagashima K, Fujiwara T, Fujiwara H, Seishima M, Minatoguchi S: Functional significance and morphological characterization of starvation-induced autophagy in the adult heart. Am J Pathol 2009, 174: 1705-1714. 10.2353/ajpath.2009.080875
23. Baehrecke EH: Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 2005, 6: 505-510. 10.1038/nrm1666
24. Rothermel BA, Hill JA: Myocyte autophagy in heart disease: friend or foe? Autophagy 2007, 3: 632-634. 10.4161/auto.4913
25. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, Nishida K, Hori M, Mizushima N, Otsu K: The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007, 13: 619-624. 10.1038/nm1574
26. Guido R, De Meyer Y, Gilles W, De K, Wim M: Role of autophagy in heart failure associated with aging. Heart Fail Rev 2010, 15: 423-430. 10.1007/s10741-010-9166-6